FoxKiser
2
19M
2
0.06
1
- Areas of investment
Summary
The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Washington.
Among the most popular portfolio startups of the fund, we may highlight Mightier, WindMIL Therapeutics. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most successful fund investment fields, there are Health Care, Medical Device. The fund has no exact preference in some founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The top activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the FoxKiser, startups are often financed by Founder Collective, Bolt - Overview, Slow Ventures. The meaningful sponsors for the fund in investment in the same round are Slow Ventures, Qiming Venture Partners, Project 11 Ventures. In the next rounds fund is usually obtained by Modern Times Group (MTG).
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 1
- Rounds per year
- 0.06
- Investments by industry
- Health Care (1)
- Gaming (1)
- Video Games (1)
- Medical Device (1)
- Therapeutics (1) Show 1 more
- Investments by region
-
- United States (2)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| WindMIL Therapeutics | 18 Jun 2018 | Biotechnology, Medical Device, Therapeutics | Early Stage Venture | 32M | United States, New Jersey |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.